PRESS RELEASE: The North Carolina Diabetes Research Center (NCDRC) was funded in 2020 as part of the NIH/NIDDK DRC consortium, which currently consists of nine centers nationwide. The NCDRC is led by Principal Investigators Donald McClain, MD, PhD (WF), John Buse, MD, PhD (UNC), Elimelda Ongeri, PhD (NC A&T) and David D’Alessio, MD (Duke). As NCDRC reports, these institutions "currently garner over $70 million annually for support of their diabetes research."
The center is focused on three featured Cores: Metabolomics, Genomics and Proteomics Core, and Advanced Clinical Studies Methods cores. The driving energy of these cores: translation. As stated in the welcome letter,
The primary mission of the NCDRC is to provide to you, both established investigators and those new to diabetes research, with access to powerful research technologies to enhance the impact of your work, as well as to connect you with collaborators, both at intra- and inter-institutional levels, to expand the scope of your project.
The NCDRC also announced its annual meeting, the 2020 NCDRC Symposium, featuring keynote speakers Al Powers, MD (Vanderbilt University), and Steven Kahn, MB, ChB (University of Washington). NCDRC's Pilot and Feasibility program seeks to enable researcher's efforts to forward and expand their research regionally, calling these efforts a “crucial aspect” of the research center.
Explore all the NCDRC has to offer at ncdiabetesresearch.org